qPCR Congress 2010
qPCR Congress - 15th - 16th November 2010, London UK
qPCR Congress 2010 is administered by Osney Media.
Next Event
2 Day Programme
qPCR Congress 2010
15th & 16th November
Monday 15th November 2010 to Tuesday 16th November 2010
London, UK, -
Ł650.00/person

Over two days, the event will attract over 120 senior-level decision makers working in qPCR from the UK, Europe and US. This conference explores effective strategies, technologies and applications of qPCR in accelerating drug discovery and development of clinical diagnostics

 

The event provides a forum for practitioners and prominent innovators to learn more about key solutions being provided to their industry, network with their peers, and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment, during a 2 day conference programme 

 

Day 1 

Stream 1: qPCR in Diagnostics and Molecular Markers  as well as Novel Technical Approaches

  • Successful Gene Expression Analysis using real-time PCR
  • Profiling technologies: multivariate and multiway expression profiling, temporal expression profiling and spatiotemporal maps
  • Other technologies: High resolution melt, Immuno PCR, Methylation sensitive PCR, SNP analysis, microRNA detection and Multiplex technologies
  • Development of clinical diagnostics and clinical Development – use in therapeutic areas such as cancer and infectious diseases

Stream 2:  Bioinformatics and Data Management

  • Bioinformatics
  • Data management: software applications, data mining, data visualization, biostatistics, multivariate statistics

Day 2

Stream 1: qPCR in Drug Discovery and Development

  • Assay optimisation and validation strategies
  • New applications of qPCR- High throughput applications, Real-time RT-PCR arrays and Digital PCR
  • The discovery of Biomarkers: Disease markers, Tissue specific markers, Cancer markers, Stem cells, Differentiation markers and Cancer stem cells
  • The potential and use of qPCR reagents and instrumentation

Stream 2: Next Generation Sequencing – High Throughput Sequencing Platforms

 

Hear insights and views from our leading line up of industry experts:
Prof. Claudio Orlando, Professor, Clinical Biochemistry Unit, Department of Clinical Physiopathology, University of Florence
Dr. Neven Zoric, CEO, TATAA Biocenter
Susanne Heinsohn, University Hospital Hamburg-Eppendorf, Clinic for Hematology and Oncology, Germany
Afif Abdel Nour, Research Scientist, Molecular Biotechnology, Institut Polytechnique LaSalle Beauvais
Dr. Raffaele Di Francia, Lab of Molecular Hematology, Institute of Tumors G. Pascale
Dr. Mathias Schmidt, Associate Principal, Strategic Planning and Business Support, Nycomed GmbH
Dr Veronika Okršlar, Biopharmaceuticals, Cell and Molecular Biology, Lek Pharmaceuticals d.d.a. Sandoz Company
Sami Hokkanen, Senior Biostatician, Research & Translational Statistics, Biostatistics & Support Functions, R&D, Orion Pharma
Dr. Benaissa El-Moualij, Center of Immunology, Institute of Pathology, University of Liege
Paul E. Kroeger, Senior Group Leader GPRD, Neuroscience & Pain Discovery, Abbott Laboratories
Dr Gustavo H. Kijak, Chief of Section Host Genetics, Military HIV Program, Henry M Jackson Foundation
Dr. Jan Kristek, Director and Head of Immunological Department, Karlovarske Imunologicke Centrum
Dr Jo Woods, Senior Research Scientist, MedImmune
Dr Jeroen Aerssens, Head Translational Genomics & Genetics, European Discovery Capabilities, Tibotec BVBA - Johnson & Johnson
Dr. Hansjoerg Keller, Senior Research Investigator, Novartis
Dr. Rolf Studer, Senior Lab Head, Actelion
Andreas Weinhausel, Senior Scientist, Molecular Diagnostics, Austrian Research Centers ARC
Dr Viktor Lakics, Senior Research Scientist - Neurodegeneration DHT, Eli Lilly
Dr. Nana Jacobsen, Senior Scientist, Exiqon
Dr Ales Trichopad, Co Founder and CTO, Labonnet
Dr. Ian Kavanagh, Research and Develoment Manager, Thermo Scientific Genomics
Dr. Emiliano Toso Head of the Molecular Biology Laboratory RBM Merk Serono
Senior Representative, Qiagen
Prof. Michael Kubista, Head Laboratoř genové exprese, Biotechnologický ústav AV ČR
Dr Dan Turner, Head of Sequencing Technology, Wellcome Trust Sanger Institute
Dr. Victor Turcanu, Lecturer in Paediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London
Patricia McLoughlin, Head of Genomics, F. Hoffmann-La Roche Ltd
Dr Olivier Grenet, Group Head Genome Biology, Investigative Toxicology, Translational Sciences, Novartis Pharma
Dr Andrej-Nikolai Speiss, Department of Andrology, University Hospital Hamburg-Eppendorf
Dr Roman Artymyshyn, Principal Scientist, Target Discovery and Assessment, Lundbeck Research
Jean-Luc Henrioul, Commercial and Business Development Director, BioXpr
Dr Marco Tomasetti, Department of Molecular Pathology and Innovative Therapies, Polytechnic University of Marche, Italy
Ralf Mauritz, Director, R&D, Roche Diagnostics GmbH
Dr Chaminda Salgado, Head of PCR Services, Pharmaceutical Analysis, NDA Analytics
Dr Natasha Paul, Senior Staff Scientist, TriLink Biotechnologies
Dr. Jan M. Ruijter, Department of Anatomy and Embryology, Academic Medical Centre, Amsterdam
Mirco Castoldi, Postdoctoral Fellow, Hentze Group, EMBL Heidelberg, Germany
Dr. Thorsten Traeger, Project Manager, R&D, Qiagen
Stig Ove Hjelmevoll, Scientist, Department of Microbiology and Infection Control, University Hospital of North Norway
Home | About The Event | 2 Day Programme | 3rd Day Workshop | Co-located NGS | Event Format | Speakers | Delegates | Solution Providers | Testimonials | Media Partners | Submit a Poster | Press Centre | Venue | Organisers | Other Events | Contact | Next Event | Book Online | 
© qPCR Congress 2010